Sonolysis in risk reduction of symptomatic and silent brain infarctions during coronary stenting (SONOREDUCE): Randomized, controlled trial

Article ID	Journal	Published Year	Pages	File Type
8661761	International Journal of Cardiology	2018	27 Pages	PDF

Abstract

Sonolysis does not reduce the risk of new brain infarcts after CS. The effect of sonolysis on number and volume of ischemic lesions and cognitive function should be assessed in further studies.

Keywords

IQR TIC PCI TIA DWI MMSE VFT CDT MRS ACE-R CAS TCD ADC ICA MCA Coronary artery stenting rt-PA angioplasty Stenting MRI Verbal fluency test diffusion-weighted imaging Magnetic resonance imaging CABG transient ischemic attack transcranial Doppler Clock Drawing Test Sonolysis Stroke body mass index BMI internal carotid artery Ischemic lesion apparent diffusion coefficient Coronary artery Recombinant tissue plasminogen activator interquartile range percutaneous coronary intervention Mini Mental State Examination Modified Rankin scale odds ratio Coronary artery bypass graft

Related Topics

Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine

Preview

Sonolysis in risk reduction of symptomatic and silent brain infarctions during coronary stenting (SONOREDUCE): Randomized, controlled trial

Authors

DaÅ¡a Viszlayová, Miroslav Brozman, KateÅina Langová, Roman Herzig, David Å koloudÃk, a SONOREDUCE Trial Group a SONOREDUCE Trial Group,